Zimmer Biomet Stock Price, News & Analysis (NYSE:ZBH)

$122.10 -0.19 (-0.16 %)
(As of 01/16/2018 04:36 AM ET)
Previous Close$122.29
Today's Range$121.58 - $123.04
52-Week Range$108.03 - $133.49
Volume1.01 million shs
Average Volume1.42 million shs
Market Capitalization$24.72 billion
P/E Ratio38.04
Dividend Yield0.79%
Beta1.15

About Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet logoZimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Receive ZBH News and Ratings via Email

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNYSE:ZBH
CUSIPN/A
Phone+1-574-2676131

Debt

Debt-to-Equity Ratio0.88%
Current Ratio1.47%
Quick Ratio0.78%

Price-To-Earnings

Trailing P/E Ratio38.0373831775701
Forward P/E Ratio15.21
P/E Growth1.9

Sales & Book Value

Annual Sales$7.68 billion
Price / Sales3.22
Cash Flow$13.37 per share
Price / Cash9.13
Book Value$48.28 per share
Price / Book2.53

Profitability

Trailing EPS$3.21
Net Income$305.90 million
Net Margins8.36%
Return on Equity16.29%
Return on Assets6.17%

Miscellaneous

Employees18,500
Outstanding Shares202,470,000

Zimmer Biomet (NYSE:ZBH) Frequently Asked Questions

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet declared a quarterly dividend on Monday, December 18th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.24 per share on Monday, January 29th. This represents a $0.96 annualized dividend and a dividend yield of 0.79%. The ex-dividend date is Thursday, December 28th. View Zimmer Biomet's Dividend History.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings Inc (NYSE:ZBH) announced its quarterly earnings results on Wednesday, November, 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing analysts' consensus estimates of $1.74 by $0.02. The medical equipment provider had revenue of $1.82 billion for the quarter, compared to analysts' expectations of $1.83 billion. Zimmer Biomet had a net margin of 8.36% and a return on equity of 16.29%. The company's revenue was down .8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.79 earnings per share. View Zimmer Biomet's Earnings History.

When will Zimmer Biomet make its next earnings announcement?

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Monday, January, 29th 2018. View Earnings Estimates for Zimmer Biomet.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet issued an update on its FY17 earnings guidance on Wednesday, November, 1st. The company provided earnings per share (EPS) guidance of $8.01-$8.07 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.23. The company issued revenue guidance of $7.76-$7.80 billion, compared to the consensus revenue estimate of $7.83 billion.Zimmer Biomet also updated its Q4 guidance to $2.08-$2.14 EPS.

Where is Zimmer Biomet's stock going? Where will Zimmer Biomet's stock price be in 2018?

21 brokers have issued 12 month price objectives for Zimmer Biomet's shares. Their predictions range from $120.00 to $158.00. On average, they anticipate Zimmer Biomet's share price to reach $137.42 in the next twelve months. View Analyst Ratings for Zimmer Biomet.

What are Wall Street analysts saying about Zimmer Biomet stock?

Here are some recent quotes from research analysts about Zimmer Biomet stock:

  • 1. Canaccord Genuity analysts commented, "We maintain our HOLD rating following the announcement that Zimmer has named Bryan Hanson, former EVP and President of Medtronic’s Minimally Invasive Therapies Group, as CEO effective immediately. The announcement ends the five-month search for a new leader after former CEO David Dvorak resigned early in the Q3/17. Additionally, interim CEO Dan Florin will remain with the company as CFO. We view the hire positively as it removes the near-term overhang of management uncertainty and adds a seasoned medtech veteran to the management team and board. Additionally, we expect the new CEO to be well received by investors given our recent diligence suggested Mr. Hanson was at the top of investors’ short list of potential candidates." (12/19/2017)
  • 2. According to Zacks Investment Research, "Zimmer Biomet ended the third quarter 2017 on a dismal note with earnings below the Zacks Consensus Estimate and revenues in line with the same. Sales were declining within most of the core segments primarily due to the slower pace of supply recovery and sales recapture of certain key brands particularly in the United States and softened domestic market conditions. The lowered 2017 guidance also added to our concerns indicating little chances of recovery ahead. Over, the last three months, the company has been observed to trade below the broader industry. Nevertheless, we look forward to the expected synergy from the LDR Holding acquisition, which should broaden and complement the company's musculoskeletal offering. We are also impressed by the strong strategic and financial goals which the combined entity expects to reach, now that the deal has been closed." (11/20/2017)
  • 3. Needham & Company LLC analysts commented, "We hosted a dinner and investor meetings with Dan Florin, Senior Vice President and CFO, and Bob Marshall, Treasurer and Vice President of Investor Relations this week in New York City. We think that the discussion was upbeat and highlighted ZBH's progress in addressing its manufacturing challenges, its non-recon business performance, margin opportunities, and cash flow outlook. The meetings reinforced our view that ZBH should be able to drive its revenue growth to sustainable mid-single digit growth with a combination of market growth in recon and above-market growth in its non-recon businesses. We reiterate our Strong Buy rating." (2/17/2017)

Who are some of Zimmer Biomet's key competitors?

Who are Zimmer Biomet's key executives?

Zimmer Biomet's management team includes the folowing people:

  • Bryan C. Hanson, President, Chief Executive Officer, Director (Age 50)
  • Daniel P. Florin, Chief Financial Officer, Senior Vice President (Age 53)
  • Robert D. Delps, President, Americas
  • Katarzyna Mazur-Hofsaess M.D. Ph.D., President, Europe, Middle East and Africa (Age 52)
  • Sang Yi, President, Asia Pacific (Age 54)
  • Chad F. Phipps, Senior Vice President, General Counsel, Secretary (Age 44)
  • Larry C. Glasscock, Independent Non-Executive Chairman of the Board (Age 69)
  • Christopher B. Begley, Independent Director (Age 65)
  • Betsy J. Bernard, Independent Director (Age 61)
  • Gail Koziara Boudreaux, Independent Director (Age 56)

Who owns Zimmer Biomet stock?

Zimmer Biomet's stock is owned by many different of retail and institutional investors. Top institutional investors include Hexavest Inc. (0.16%), Stock Yards Bank & Trust Co. (0.03%), Exxonmobil Investment Management Inc. TX (0.02%), QUANTRES ASSET MANAGEMENT Ltd (0.01%), Daiwa SB Investments Ltd. (0.00%) and Boltwood Capital Management (0.00%). Company insiders that own Zimmer Biomet stock include Blackstone Capital Partners V, Chad F Phipps, Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Sang Yi, Stuart G Kleopfer and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

Who sold Zimmer Biomet stock? Who is selling Zimmer Biomet stock?

Zimmer Biomet's stock was sold by a variety of institutional investors in the last quarter, including Exxonmobil Investment Management Inc. TX, Stock Yards Bank & Trust Co. and Boyd Watterson Asset Management LLC OH. Company insiders that have sold Zimmer Biomet company stock in the last year include Chad F Phipps, David C Dvorak, Sang Yi and Tony W Collins. View Insider Buying and Selling for Zimmer Biomet.

Who bought Zimmer Biomet stock? Who is buying Zimmer Biomet stock?

Zimmer Biomet's stock was purchased by a variety of institutional investors in the last quarter, including QUANTRES ASSET MANAGEMENT Ltd, Hexavest Inc., Boltwood Capital Management, Chesley Taft & Associates LLC and Daiwa SB Investments Ltd.. View Insider Buying and Selling for Zimmer Biomet.

How do I buy Zimmer Biomet stock?

Shares of Zimmer Biomet can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zimmer Biomet's stock price today?

One share of Zimmer Biomet stock can currently be purchased for approximately $122.10.

How big of a company is Zimmer Biomet?

Zimmer Biomet has a market capitalization of $24.72 billion and generates $7.68 billion in revenue each year. The medical equipment provider earns $305.90 million in net income (profit) each year or $3.21 on an earnings per share basis. Zimmer Biomet employs 18,500 workers across the globe.

How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 E Main St, WARSAW, IN 46580-2746, United States. The medical equipment provider can be reached via phone at +1-574-2676131 or via email at [email protected]


MarketBeat Community Rating for Zimmer Biomet (ZBH)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  567 (Vote Outperform)
Underperform Votes:  442 (Vote Underperform)
Total Votes:  1,009
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Zimmer Biomet (NYSE:ZBH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.812.682.672.74
Ratings Breakdown: 0 Sell Rating(s)
5 Hold Rating(s)
15 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
16 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $137.42$135.75$138.47$139.57
Price Target Upside: 10.17% upside19.56% upside18.26% upside5.25% upside

Zimmer Biomet (NYSE:ZBH) Consensus Price Target History

Price Target History for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2018Canaccord GenuityReiterated RatingHold$132.00LowView Rating Details
1/5/2018Cantor FitzgeraldReiterated RatingOverweight -> OverweightLowView Rating Details
12/19/2017Goldman Sachs GroupUpgradeSell -> Neutral$125.00LowView Rating Details
12/19/2017OppenheimerReiterated RatingBuyMediumView Rating Details
12/19/2017Wells Fargo & CoUpgradeMarket Perform -> OutperformLowView Rating Details
12/12/2017BMO Capital MarketsReiterated RatingBuy$142.00LowView Rating Details
11/14/2017Deutsche BankUpgradeHold -> Buy$128.00N/AView Rating Details
11/9/2017Edward JonesUpgradeHold -> BuyN/AView Rating Details
11/7/2017Royal Bank of CanadaLower Price TargetOutperform$125.00N/AView Rating Details
11/3/2017Stifel NicolausReiterated RatingHold$120.00N/AView Rating Details
11/3/2017Jefferies GroupReiterated RatingBuy$136.00N/AView Rating Details
11/2/2017Morgan StanleyLower Price TargetOverweight$146.00 -> $136.00N/AView Rating Details
11/2/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
11/1/2017SunTrust BanksSet Price TargetBuy$136.00N/AView Rating Details
8/24/2017GabelliInitiated CoverageBuy$142.00LowView Rating Details
7/28/2017Leerink SwannBoost Price TargetOutperform$141.00 -> $146.00LowView Rating Details
7/14/2017Bank of AmericaReiterated RatingBuy -> Buy$158.00MediumView Rating Details
7/12/2017Needham & Company LLCReiterated RatingStrong-Buy$153.00LowView Rating Details
7/12/2017GuggenheimUpgradeNeutral -> Buy$157.00MediumView Rating Details
6/9/2017CitigroupBoost Price TargetNeutral$108.00 -> $130.00LowView Rating Details
2/1/2017Robert W. BairdReiterated RatingOutperform$130.00 -> $136.00N/AView Rating Details
1/5/2017JPMorgan Chase & Co.Set Price TargetBuy$134.00N/AView Rating Details
11/8/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/22/2016ArgusReiterated RatingBuy$140.00N/AView Rating Details
8/23/2016BarclaysBoost Price TargetOverweight$140.00 -> $145.00N/AView Rating Details
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 -> $145.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$123.00N/AView Rating Details
1/31/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/29/2016Northland SecuritiesLower Price Target$109.00 -> $105.00N/AView Rating Details
(Data available from 1/16/2016 forward)

Earnings

Zimmer Biomet (NYSE:ZBH) Earnings History and Estimates Chart

Earnings by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE ZBH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/29/2018N/AView Earnings Details
11/1/2017Q3 2017$1.74$1.72$1.83 billion$1.82 billionViewN/AView Earnings Details
7/27/2017Q2 2017$2.10$2.08$1.95 billion$1.95 billionViewN/AView Earnings Details
4/27/2017Q1 2017$2.11$2.13$1.96 billion$1.98 billionViewN/AView Earnings Details
1/31/2017Q416$2.11$2.14$1.98 billion$2.01 billionViewListenView Earnings Details
10/31/2016Q316$1.79$1.79$950.20 million$1.83 billionViewListenView Earnings Details
7/28/2016Q216$1.97$2.02$1.90 billion$1.93 billionViewListenView Earnings Details
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details
7/30/2015Q2 2015$1.56$1.59ViewN/AView Earnings Details
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details
10/25/2012$1.13$1.15ViewN/AView Earnings Details
7/26/2012$1.32$1.34ViewN/AView Earnings Details
4/26/2012$1.30$1.30ViewN/AView Earnings Details
1/26/2012$1.34$1.36ViewN/AView Earnings Details
10/27/2011$1.03$1.04ViewN/AView Earnings Details
7/27/2011$1.19$1.21ViewN/AView Earnings Details
4/28/2011$1.12$1.19ViewN/AView Earnings Details
1/27/2011$1.19$1.21ViewN/AView Earnings Details
10/28/2010Q3 2010$0.95$0.96ViewN/AView Earnings Details
7/22/2010Q2 2010$1.05$1.09ViewN/AView Earnings Details
4/22/2010Q1 2010$1.01$1.02ViewN/AView Earnings Details
1/28/2010Q4 2009$1.08$1.12ViewN/AView Earnings Details
10/22/2009Q3 2009$0.85$0.88ViewN/AView Earnings Details
7/23/2009Q2 2009$0.96$1.01ViewN/AView Earnings Details
4/23/2009Q1 2009$0.94$0.95ViewN/AView Earnings Details
1/29/2009Q4 2008$1.00$1.00ViewN/AView Earnings Details
10/23/2008Q3 2008$0.89$0.97ViewN/AView Earnings Details
7/22/2008Q2 2008$1.03$1.03ViewN/AView Earnings Details
4/24/2008Q1 2008$1.04$1.04ViewN/AView Earnings Details
1/29/2008Q4 2007$1.04$1.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Zimmer Biomet (NYSE:ZBH) Earnings Estimates

2018 EPS Consensus Estimate: $8.14
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$1.92$2.10$2.00
Q2 20185$1.92$2.14$2.00
Q3 20185$1.84$1.98$1.89
Q4 20185$2.22$2.29$2.25
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Zimmer Biomet (NYSE:ZBH) Dividend Information

Next Dividend:1/29/2018
Annual Dividend:$0.96
Dividend Yield:0.79%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:29.91% (Trailing 12 Months of Earnings)
11.96% (Based on This Year's Estimates)
11.74% (Based on Next Year's Estimates)
Track Record:2 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/18/2017quarterly$0.240.79%12/28/201712/29/20171/29/2018
8/7/2017quarterly$0.240.83%9/21/20179/22/201710/27/2017
5/30/2017quarterly$0.240.81%6/21/20176/23/20177/28/2017
3/1/2017quarterly$0.240.81%3/29/20173/31/20174/28/2017
12/19/2016quarterly$0.240.94%12/28/201612/30/20161/27/2017
8/23/2016quarterly$0.240.74%9/21/20169/23/201610/28/2016
5/23/2016quarterly$0.246/22/20166/24/20167/29/2016
2/24/2016quarterly$0.240.99%3/29/20163/31/20164/29/2016
12/14/2015quarterly$0.220.87%12/29/201512/31/20151/29/2016
8/24/2015quarterly$0.220.9%9/28/20159/30/201510/30/2015
5/5/2015quarterly$0.220.8%5/13/20155/15/20157/14/2015
2/24/2015quarterly$0.220.73%3/4/20153/6/20154/24/2015
12/15/2014quarterly$0.220.81%12/24/201412/29/20141/30/2015
8/26/2014quarterly$0.220.87%9/24/20149/26/201410/31/2014
5/23/2014quarterly$0.220.86%6/25/20146/27/20147/25/2014
3/5/2014quarterly$0.220.9%3/26/20143/28/20144/25/2014
12/16/2013quarterly$0.200.88%12/24/201312/27/20131/31/2014
9/9/2013quarterly$0.200.99%9/25/20139/27/201310/25/2013
6/14/2013quarterly$0.201.03%6/26/20136/28/20137/26/2013
3/8/2013quarterly$0.201.06%3/26/20133/29/20134/26/2013
12/14/2012quarterly$0.181.06%12/24/201212/27/20121/25/2013
(Data available from 1/1/2013 forward)

Insider Trades

Zimmer Biomet (NYSE ZBH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.07%
Institutional Ownership Percentage: 86.06%
Insider Trades by Quarter for Zimmer Biomet (NYSE:ZBH)
Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE ZBH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/31/2017Tony W. CollinsVPSell16,986$121.74$2,067,875.64View SEC Filing  
6/12/2017Sang YiInsiderSell17,731$124.56$2,208,573.36View SEC Filing  
5/5/2017Chad F. PhippsVPSell6,200$116.76$723,912.00View SEC Filing  
4/27/2017David C DvorakInsiderSell87,331$116.47$10,171,441.57381,886View SEC Filing  
3/20/2017David C DvorakInsiderSell1,040$121.63$126,495.20294,077View SEC Filing  
12/2/2016David A. Jr. NolanInsiderSell5,050$101.11$510,605.50View SEC Filing  
9/8/2016Daniel E WilliamsonInsiderSell2,716$129.96$352,971.362,000View SEC Filing  
8/23/2016Stuart G KleopferInsiderSell3,397$129.71$440,624.873,000View SEC Filing  
8/12/2016Tony W. CollinsVPSell1,287$129.16$166,228.92View SEC Filing  
8/9/2016Stuart G KleopferInsiderSell533$132.71$70,734.436,397View SEC Filing  
8/1/2016David A. Jr. NolanInsiderSell25,255$130.77$3,302,596.35View SEC Filing  
7/11/2016Daniel P FlorinCFOSell15,000$124.98$1,874,700.0016,983View SEC Filing  
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.733,245View SEC Filing  
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.007,609View SEC Filing  
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.0028,415View SEC Filing  
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.0038,415View SEC Filing  
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40277,416View SEC Filing  
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06244,502View SEC Filing  
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.7012,139View SEC Filing  
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.005,211View SEC Filing  
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.0017,240View SEC Filing  
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.005,211View SEC Filing  
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.565,211View SEC Filing  
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.002,791View SEC Filing  
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.0017,240View SEC Filing  
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00172,746View SEC Filing  
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.007,924View SEC Filing  
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.201,643View SEC Filing  
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Zimmer Biomet (NYSE ZBH) News Headlines

Source:
DateHeadline
$2.10 Earnings Per Share Expected for Zimmer Biomet Holdings Inc (ZBH) This Quarter$2.10 Earnings Per Share Expected for Zimmer Biomet Holdings Inc (ZBH) This Quarter
www.americanbankingnews.com - January 15 at 1:08 AM
Equities Analysts Offer Predictions for Zimmer Biomet Holdings Incs FY2017 Earnings (ZBH)Equities Analysts Offer Predictions for Zimmer Biomet Holdings Inc's FY2017 Earnings (ZBH)
www.americanbankingnews.com - January 10 at 6:28 AM
FDA Nod for Zimmer Biomets Sidus, Aids Arthroplasty ArmFDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm
www.zacks.com - January 8 at 10:41 AM
FDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty ArmFDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm
finance.yahoo.com - January 8 at 10:41 AM
Zimmer Biomet (ZBH) Rating Reiterated by Cantor FitzgeraldZimmer Biomet (ZBH) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - January 6 at 11:10 PM
Zimmer Biomet (ZBH) Given Hold Rating at Canaccord GenuityZimmer Biomet (ZBH) Given Hold Rating at Canaccord Genuity
www.americanbankingnews.com - January 5 at 1:34 PM
Zimmer Biomet Holdings (ZBH) FDA Clearance of the Sidus Stem-Free Shoulder System - StreetInsider.comZimmer Biomet Holdings (ZBH) FDA Clearance of the Sidus Stem-Free Shoulder System - StreetInsider.com
www.streetinsider.com - January 5 at 10:42 AM
Zimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Buy" by BrokeragesZimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - January 5 at 6:00 AM
Zimmer Biomet Holdings (ZBH) FDA Clearance of the Sidus Stem-Free Shoulder SystemZimmer Biomet Holdings (ZBH) FDA Clearance of the Sidus Stem-Free Shoulder System
www.streetinsider.com - January 4 at 10:26 AM
Zimmer Biomet Announces FDA Clearance of the Sidus® Stem-Free Shoulder SystemZimmer Biomet Announces FDA Clearance of the Sidus® Stem-Free Shoulder System
finance.yahoo.com - January 4 at 10:26 AM
What Zimmer Biomet’s Progress II Study Success Could MeanWhat Zimmer Biomet’s Progress II Study Success Could Mean
finance.yahoo.com - January 4 at 10:26 AM
Where Zimmer Biomet’s Leadership Stands NowWhere Zimmer Biomet’s Leadership Stands Now
finance.yahoo.com - January 3 at 4:22 PM
Zimmer Biomet on the Street: How the Analysts Are LeaningZimmer Biomet on the Street: How the Analysts Are Leaning
finance.yahoo.com - January 3 at 9:43 AM
Zimmer Biomet to Present at 36th Annual JP Morgan Healthcare Conference - PR Newswire (press release)Zimmer Biomet to Present at 36th Annual JP Morgan Healthcare Conference - PR Newswire (press release)
www.prnewswire.com - January 2 at 5:12 PM
Zimmer Biomet to Present at 36th Annual J.P. Morgan Healthcare ConferenceZimmer Biomet to Present at 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 5:02 PM
$2.03 Billion in Sales Expected for Zimmer Biomet Holdings Inc (ZBH) This Quarter$2.03 Billion in Sales Expected for Zimmer Biomet Holdings Inc (ZBH) This Quarter
www.americanbankingnews.com - December 31 at 10:54 AM
 Brokerages Anticipate Zimmer Biomet Holdings Inc (ZBH) Will Post Earnings of $2.10 Per Share Brokerages Anticipate Zimmer Biomet Holdings Inc (ZBH) Will Post Earnings of $2.10 Per Share
www.americanbankingnews.com - December 29 at 5:26 AM
Zimmer Biomet Holdings, Inc. (ZBH) Ex-Dividend Date Scheduled for December 28, 2017 - NasdaqZimmer Biomet Holdings, Inc. (ZBH) Ex-Dividend Date Scheduled for December 28, 2017 - Nasdaq
www.nasdaq.com - December 27 at 1:38 PM
Blog Exposure - Zimmer Biomet Announced Publication of Positive Results from PROGRESS II Trial of nSTRIDE® APS Kit for Knee Osteoarthritis TreatmentBlog Exposure - Zimmer Biomet Announced Publication of Positive Results from PROGRESS II Trial of nSTRIDE® APS Kit for Knee Osteoarthritis Treatment
finance.yahoo.com - December 27 at 1:04 PM
Virco Manufacturing Corporation (VIRC) Ex-Dividend Date Scheduled forVirco Manufacturing Corporation (VIRC) Ex-Dividend Date Scheduled for
www.nasdaq.com - December 26 at 10:16 AM
Zimmer Biomet Strong on Positive Data From PROGRESS II StudyZimmer Biomet Strong on Positive Data From PROGRESS II Study
finance.yahoo.com - December 26 at 10:16 AM
Zimmer Biomet Suffers a Dull Knee Business & Supply DelayZimmer Biomet Suffers a Dull Knee Business & Supply Delay
finance.yahoo.com - December 26 at 10:16 AM
Equities Analysts Offer Predictions for Zimmer Biomet Holdings Incs Q1 2018 Earnings (ZBH)Equities Analysts Offer Predictions for Zimmer Biomet Holdings Inc's Q1 2018 Earnings (ZBH)
www.americanbankingnews.com - December 25 at 4:50 AM
Zimmer Biomet Sees Unusually High Options Volume (ZBH)Zimmer Biomet Sees Unusually High Options Volume (ZBH)
www.americanbankingnews.com - December 23 at 1:10 AM
Zimmer Biomet Holdings (ZBH) Reports Publication of Positive ... - StreetInsider.comZimmer Biomet Holdings (ZBH) Reports Publication of Positive ... - StreetInsider.com
www.streetinsider.com - December 22 at 11:31 PM
Zimmer Biomets APS Kit for knee osteoarthritis shows treatment benefit in studyZimmer Biomet's APS Kit for knee osteoarthritis shows treatment benefit in study
www.msn.com - December 22 at 6:23 PM
Zimmer Biomet Announces Publication of Positive Results from PROGRESS II Trial of Autologous Protein Solution Prepared with nSTRIDE® APS Kit in Treating Osteoarthritis of the KneeZimmer Biomet Announces Publication of Positive Results from PROGRESS II Trial of Autologous Protein Solution Prepared with nSTRIDE® APS Kit in Treating Osteoarthritis of the Knee
finance.yahoo.com - December 22 at 6:23 PM
Q2 2018 EPS Estimates for Zimmer Biomet Holdings Inc (ZBH) Decreased by AnalystQ2 2018 EPS Estimates for Zimmer Biomet Holdings Inc (ZBH) Decreased by Analyst
www.americanbankingnews.com - December 22 at 1:02 PM
Zimmer Biomet Holdings, Inc. is trading above its 50 day moving average : ZBH-US : December 21, 2017Zimmer Biomet Holdings, Inc. is trading above its 50 day moving average : ZBH-US : December 21, 2017
finance.yahoo.com - December 21 at 10:30 AM
FY2017 EPS Estimates for Zimmer Biomet Holdings Inc (ZBH) Reduced by AnalystFY2017 EPS Estimates for Zimmer Biomet Holdings Inc (ZBH) Reduced by Analyst
www.americanbankingnews.com - December 21 at 8:00 AM
Recent ZBH NewsRecent ZBH News
www.bloomberg.com - December 20 at 10:41 AM
Why Darden Restaurants, Zimmer Biomet Holdings, and Applied ... - Motley FoolWhy Darden Restaurants, Zimmer Biomet Holdings, and Applied ... - Motley Fool
www.fool.com - December 20 at 10:33 AM
Zimmer Biomet (ZBH) Surges: Stock Moves 6.1% HigherZimmer Biomet (ZBH) Surges: Stock Moves 6.1% Higher
finance.yahoo.com - December 20 at 10:33 AM
Zimmer Biomet (ZBH) Lifted to Neutral at Goldman Sachs GroupZimmer Biomet (ZBH) Lifted to Neutral at Goldman Sachs Group
www.americanbankingnews.com - December 19 at 9:02 PM
Zimmer Biomet Holdings (ZBH) Declares $0.24 Quarterly Dividend; 0.8% YieldZimmer Biomet Holdings (ZBH) Declares $0.24 Quarterly Dividend; 0.8% Yield
www.streetinsider.com - December 19 at 4:18 PM
ZBH Crosses Above Key Moving Average LevelZBH Crosses Above Key Moving Average Level
www.nasdaq.com - December 19 at 4:18 PM
S&P 500 Movers: PPL, ZBHS&P 500 Movers: PPL, ZBH
www.msn.com - December 19 at 4:18 PM
US STOCKS-Apple leads Wall St lower as tax-bill vote loomsUS STOCKS-Apple leads Wall St lower as tax-bill vote looms
finance.yahoo.com - December 19 at 4:18 PM
Canaccord Genuity Reaffirms "Hold" Rating for Zimmer Biomet (ZBH)Canaccord Genuity Reaffirms "Hold" Rating for Zimmer Biomet (ZBH)
www.americanbankingnews.com - December 19 at 4:04 PM
Zimmer Biomets (ZBH) Buy Rating Reaffirmed at OppenheimerZimmer Biomet's (ZBH) Buy Rating Reaffirmed at Oppenheimer
www.americanbankingnews.com - December 19 at 2:00 PM
Zimmer Biomet (ZBH) Upgraded to "Outperform" at Wells Fargo & CompanyZimmer Biomet (ZBH) Upgraded to "Outperform" at Wells Fargo & Company
www.americanbankingnews.com - December 19 at 12:28 PM
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of ... - PR Newswire (press release)Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of ... - PR Newswire (press release)
www.prnewswire.com - December 19 at 10:33 AM
Zimmer Biomet Holdings (ZBH) Names Bryan C. Hanson as President and CEO - StreetInsider.comZimmer Biomet Holdings (ZBH) Names Bryan C. Hanson as President and CEO - StreetInsider.com
www.streetinsider.com - December 19 at 10:33 AM
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2017Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2017
finance.yahoo.com - December 19 at 10:33 AM
Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive OfficerZimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer
finance.yahoo.com - December 19 at 10:33 AM
Zimmer Biomet Holdings Inc to Issue Quarterly Dividend of $0.24 (ZBH)Zimmer Biomet Holdings Inc to Issue Quarterly Dividend of $0.24 (ZBH)
www.americanbankingnews.com - December 19 at 12:08 AM
Traders Purchase High Volume of Put Options on Zimmer Biomet (ZBH)Traders Purchase High Volume of Put Options on Zimmer Biomet (ZBH)
www.americanbankingnews.com - December 18 at 3:10 AM
BMO Capital Markets Reaffirms "Buy" Rating for Zimmer Biomet (ZBH)BMO Capital Markets Reaffirms "Buy" Rating for Zimmer Biomet (ZBH)
www.americanbankingnews.com - December 12 at 8:38 PM
Zimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Hold" by BrokeragesZimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 11 at 5:56 AM
Stryker and Zimmer Biomet Holdings Settled a Trade Secret CaseStryker and Zimmer Biomet Holdings Settled a Trade Secret Case
finance.yahoo.com - December 5 at 12:15 PM

SEC Filings

Zimmer Biomet (NYSE:ZBH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Zimmer Biomet (NYSE:ZBH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Zimmer Biomet (NYSE ZBH) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.